Purpose: This study investigated the current quality of clinical trials conducted in China.
Methods: Questionnaires were administered to medical doctors belonging to institutes affiliated to Peking University in Beijing, China. The delivery and collection of questionnaires were conducted by a research team from China. Analysis and evaluation were conducted by research teams from both China and Japan.
Results: A total of 145 questionnaires were administered and 117 respondents included the name of the medical institution to which they belonged. A total of 56.3% of the respondents participated in audit and inspection by institutes and 50.5% of the respondents reported receipt of the audit findings. A further 23.6% participated in audits and inspections performed by an external authority and 20.2% reported the receipt of the audit findings.
Conclusion: Our research suggests that clinical trials in Beijing are well conducted and are monitored by both institutions and external authorities.
Copyright © 2012 Elsevier Inc. All rights reserved.